Search Results - Patrick G Morris

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma by Jack Patrick Gleeson, Fergus Keane, Niamh M. Keegan, Emin Mammadov, Emily Harrold, Abdullah Alhusaini, Jeffrey Harte, Austin Eakin‐Love, Philip J. O'Halloran, Stephen MacNally, Bryan T. Hennessy, Oscar S. Breathnach, Liam Grogan, Patrick G. Morris

    Published in Cancer Medicine (2020-01-01)
    Get full text
    Article


  2. 2

    Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study) by Gavin P. Dowling, Sinead Toomey, Philip Bredin, Imelda Parker, Eibhlin Mulroe, Jacinta Marron, Olivia McLoughlin, Ausra Teiserskiene, Colm Power, Anne Marie O’Shea, Megan Greally, Patrick G. Morris, Deirdre Duke, Arnold D. K. Hill, Bryan T. Hennessy

    Published in BMC Cancer (2024-01-01)
    Get full text
    Article


  3. 3

    Targeting the phosphatidylinositol-3-kinase (PI3K) and mitogen activated protein kinase (MAPK) signalling pathways to enhance chemoradiotherapy in locally advanced rectal cancer by Aoife Carr, Jonathan A. Coulter, Julie Workman, Joanna Fay, Angela Farrelly, Alex J. Eustace, Lindsey Bennie, Liam Grogan, Oscar Breathnach, Patrick G. Morris, Deborah A. McNamara, Mattia Cremona, Brian D.P. O'Neill, Bryan T. Hennessy, Sinead Toomey

    Get full text
    Article


  4. 4

    Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicity by Ronan Andrew McLaughlin, David McMahon, Christopher Cluxton, Orla Meave Fitzpatrick, Michael Conroy, Majid Almeraikhi, Humaid Alkaabi, Fianait Bligh, Brian O’Neill, Mayilone Arumugasamy, William Robb, Oscar Seamus Breathnach, William Grogan, Bryan T. Hennessy, Adrian Murphy, Jarsuhka Naidoo, Megan Greally, Kathleen Bennett, Patrick G Morris

    Published in BMC Cancer (2025-08-01)
    Get full text
    Article


  5. 5

    Prognostic Significance of Delays in Initiation of Adjuvant Trastuzumab-Based Therapy in Patients with HER2-Positive Breast Cancer by Gavin P. Dowling, Aisling Hegarty, Gordon R. Daly, Sandra Hembrecht, Cian M. Hehir, Gavin G. Calpin, Richard Hogan, David O’Reilly, Eithne Downey, Sinead Toomey, Liam Grogan, Oscar Breathnach, Michael Allen, Patrick G. Morris, Colm Power, Leonie S. Young, Arnold D. K. Hill, Bryan T. Hennessy

    Published in Biomedicines (2025-05-01)
    Get full text
    Article


  6. 6

    Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14–13/PrE0109) by Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, Angela DeMichele, Paolo Tarantino, Evandro de Azambuja, Georg Pfeiler, Miguel Martin, Justin M. Balko, Zbigniew Nowecki, Marija Balic, Adam M. Brufsky, Arlene Chan, Patrick G. Morris, Tufia Haddad, Sibylle Loibl, Yuan Liu, Lidija Soelkner, Christian Fesl, Erica L. Mayer, Michael Gnant, on behalf of the PALLAS groups and investigators

    Published in Breast Cancer Research (2024-10-01)
    Get full text
    Article


  7. 7

    Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer by Nicola Cosgrove, Alex J. Eustace, Peter O’Donovan, Stephen F. Madden, Bruce Moran, John Crown, Brian Moulton, Patrick G. Morris, Liam Grogan, Oscar Breathnach, Colm Power, Michael Allen, Janice M. Walshe, Arnold D. Hill, Anna Blümel, Darren O’Connor, Sudipto Das, Małgorzata Milewska, Joanna Fay, Elaine Kay, Sinead Toomey, Bryan T. Hennessy, Simon J. Furney

    Published in npj Breast Cancer (2023-09-01)
    Get full text
    Article


Search Tools: